Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present)
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present)
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 30, Issue 1, Pages 1-13
Publisher
Informa UK Limited
Online
2019-12-12
DOI
10.1080/13543776.2020.1703952
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications
- (2019) Agha Zeeshan Mirza et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Activation of PPAR-α by N-palmitoylethanolamine engages allopregnanolone biosynthesis to modulate emotional behavior
- (2019) Andrea Locci et al. BIOLOGICAL PSYCHIATRY
- DPP-4 Inhibition and the Path to Clinical Proof
- (2019) Bo Ahrén Frontiers in Endocrinology
- SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
- (2019) Anastasios Tentolouris et al. International Journal of Environmental Research and Public Health
- Advances and Challenges in Drug Design of PPARδ Ligands
- (2018) Vinicius Goncalves Maltarollo et al. CURRENT DRUG TARGETS
- Peroxisome proliferator-activated receptor alpha-mediated drug toxicity in the liver
- (2018) Maka S. Hedrington et al. Expert Opinion on Drug Metabolism & Toxicology
- Functional Regulation of PPARs through Post-Translational Modifications
- (2018) Reinhard Brunmeir et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Update on FXR Biology: Promising Therapeutic Target?
- (2018) Chang Han INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR) α/γ/δ Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate
- (2018) Benaïssa Boubia et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Combination of the Aerosolized PPAR-γ Agonist Pioglitazone and a Synthetic Surfactant Protein B Peptide Mimic Prevents Hyperoxia-Induced Neonatal Lung Injury in Rats
- (2018) Reiko Sakurai et al. Neonatology
- Peroxisome Proliferator-Activated Receptor γ Is Essential for the Resolution of Staphylococcus aureus Skin Infections
- (2018) Lance R. Thurlow et al. Cell Host & Microbe
- GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- Comparison of dipeptidyl peptidase-4 inhibitors and pioglitazone combination therapy versus pioglitazone monotherapy in type 2 diabetes
- (2018) Ben Wang et al. MEDICINE
- Thiazolidinediones and PPAR orchestra as antidiabetic agents: From past to present
- (2017) Sabina Yasmin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Distinct but complementary contributions of PPAR isotypes to energy homeostasis
- (2017) Vanessa Dubois et al. JOURNAL OF CLINICAL INVESTIGATION
- A New Agonist for Peroxisome Proliferation-activated Receptor γ (PPARγ), Fraglide-1 from Zhenjiang Fragrant Vinegar: Screening and Characterization Based on Cell Culture Experiments
- (2017) Yoshio Tsujino Journal of Oleo Science
- Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ
- (2017) Chyuan-Chuan Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of peroxisome proliferator activated receptors (PPAR)-γ and -α agonists on cochlear protection from oxidative stress
- (2017) Marijana Sekulic-Jablanovic et al. PLoS One
- Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
- (2016) Nadira Ruzehaji et al. ANNALS OF THE RHEUMATIC DISEASES
- The clearance of dying cells: table for two
- (2016) D R Green et al. CELL DEATH AND DIFFERENTIATION
- FXR Agonists: From Bench to Bedside, a Guide for Clinicians
- (2016) Ahmad Samer Alawad et al. DIGESTIVE DISEASES AND SCIENCES
- Rice Koji Extract Enhances Lipid Metabolism through Peroxisome Proliferator-Activated Receptor Alpha (PPARα) Activation in Mouse Liver
- (2016) Haruya Takahashi et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Identification and characterization of PPARα ligands in the hippocampus
- (2016) Avik Roy et al. Nature Chemical Biology
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
- (2016) Frederik Nevens et al. NEW ENGLAND JOURNAL OF MEDICINE
- PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage
- (2015) Faezeh Vasheghani et al. ANNALS OF THE RHEUMATIC DISEASES
- Identification and characterisation of a prototype for a new class of competitive PPARγ antagonists
- (2015) Tilo Knape et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Can a Selective PPARγ Modulator Improve Glycemic Control in Patients With Type 2 Diabetes With Fewer Side Effects Compared With Pioglitazone?
- (2014) Alex M. DePaoli et al. DIABETES CARE
- Effects of the Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist GW501516 on Bone and Muscle in Ovariectomized Rats
- (2014) M. P. Mosti et al. ENDOCRINOLOGY
- PPARγ ligands and their therapeutic applications: a patent review (2008 – 2014)
- (2014) Ichiro Takada et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Liver X receptors in lipid metabolism: opportunities for drug discovery
- (2014) Cynthia Hong et al. NATURE REVIEWS DRUG DISCOVERY
- Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
- (2014) Bogna Grygiel-Górniak Nutrition Journal
- Dietary habits and behaviors associated with nonalcoholic fatty liver disease
- (2014) Kenichiro Yasutake WORLD JOURNAL OF GASTROENTEROLOGY
- New Insights into the PPARγAgonists for the Treatment of Diabetic Nephropathy
- (2014) Zhanjun Jia et al. PPAR Research
- Ricekojireduced body weight gain, fat accumulation, and blood glucose level in high-fat diet-induced obese mice
- (2014) Yumiko Yoshizaki et al. PeerJ
- Functional Modularity of the Arginine Catabolic Mobile Element Contributes to the Success of USA300 Methicillin-Resistant Staphylococcus aureus
- (2013) Lance R. Thurlow et al. Cell Host & Microbe
- Targeting liver X receptors in inflammation
- (2013) Knut R Steffensen et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Harnessing the benefits of PPARβ/δ agonists
- (2013) Louise S. Mackenzie et al. LIFE SCIENCES
- Molecular Implications of the PPARs in the Diabetic Eye
- (2013) Andreea Ciudin et al. PPAR Research
- Regulation of Cyclic AMP Response Element Binding and Hippocampal Plasticity-Related Genes by Peroxisome Proliferator-Activated Receptor α
- (2013) Avik Roy et al. Cell Reports
- Selective PPARγ modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice
- (2012) Dae Ho Lee et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Fibrates: Therapeutic potential for diabetic nephropathy?
- (2012) I. Kouroumichakis et al. European Journal of Internal Medicine
- Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008–present)
- (2012) Christina Lamers et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Lipid-Modifying Therapies and Risk of Pancreatitis
- (2012) David Preiss et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Peroxisome proliferator-activated receptor delta agonist attenuates nicotine suppression effect on human mesenchymal stem cell-derived osteogenesis and involves increased expression of heme oxygenase-1
- (2012) Dong Hyun Kim et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Thiazolidinediones and PPARγ agonists: time for a reassessment
- (2012) Bertrand Cariou et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Lateral fluid percussion injury of the brain induces CCL20 inflammatory chemokine expression in rats
- (2011) Mahasweta Das et al. Journal of Neuroinflammation
- Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury
- (2010) Andrew Sauerbeck et al. EXPERIMENTAL NEUROLOGY
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
- (2010) Jang Hyun Choi et al. NATURE
- Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver
- (2009) Manu V. Chakravarthy et al. CELL
- Apoptotic Cells Promote Their Own Clearance and Immune Tolerance through Activation of the Nuclear Receptor LXR
- (2009) Noelia A-Gonzalez et al. IMMUNITY
- INT131: A Selective Modulator of PPARγ
- (2009) Alykhan Motani et al. JOURNAL OF MOLECULAR BIOLOGY
- Fat and Beyond: The Diverse Biology of PPARγ
- (2008) Peter Tontonoz et al. Annual Review of Biochemistry
- The Development of INT131 as a Selective PPAR Modulator: Approach to a Safer Insulin Sensitizer
- (2008) Linda S. Higgins et al. PPAR Research
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More